Baldermann, Juan Carlos https://orcid.org/0000-0001-5851-9268
Petry-Schmelzer, Jan Niklas
Schüller, Thomas https://orcid.org/0000-0003-1232-7871
Mahfoud, Lin
Brandt, Gregor A. https://orcid.org/0000-0002-9984-2069
Dembek, Till A.
van der Linden, Christina https://orcid.org/0000-0003-2091-4638
Krauss, Joachim K. https://orcid.org/0000-0002-0675-9064
Szejko, Natalia
Müller-Vahl, Kirsten R. https://orcid.org/0000-0002-7181-7419
Ganos, Christos
Al-Fatly, Bassam https://orcid.org/0000-0003-0067-6177
Heiden, Petra
Servello, Domenico
Galbiati, Tommaso https://orcid.org/0000-0003-1950-1633
Johnson, Kara A. https://orcid.org/0000-0001-6556-8957
Butson, Christopher R.
Okun, Michael S. https://orcid.org/0000-0002-6247-9358
Andrade, Pablo
Domschke, Katharina https://orcid.org/0000-0002-2550-9132
Fink, Gereon R. https://orcid.org/0000-0002-8230-1856
Fox, Michael D. https://orcid.org/0000-0001-8848-6399
Horn, Andreas https://orcid.org/0000-0002-0695-6025
Kuhn, Jens https://orcid.org/0000-0002-4719-5293
Visser-Vandewalle, Veerle https://orcid.org/0000-0002-5274-7929
Barbe, Michael T.
Article History
Received: 5 March 2024
Accepted: 29 November 2024
First Online: 16 December 2024
Competing interests
: C.G. was supported by the VolkswagenStiftung (Freigeist) and received lecture honoraria from the Movement Disorder Society. K.M.V. has received financial or material research support from DFG: GZ MU 1527/3–1 GZ MU 1527/3–2, and Almirall Hermal GmbH. She has received consultants and other honoraria from Canymed, Emalex, Eurox Group, Sanity Group, Stadapharm GmbH, Swiss alpinapharm, Synendos Therapeutics AG, Tetrapharm, and Triaspharm. She is an advisory/scientific board member for Branchenverband Cannabiswirtschaft e.V. (BvCW), Sanity Group, Synendos Therapeutics AG, Syqe Medical Ltd., and Therapix Biosciences Ltd. She has received speaker’s fees from Almirall, Bundesverband der pharmazeutischen Cannabinoidunternehmen (BPC), Cogitando GmbH, Emalex, Grow, Medizinischer Dienst Westfalen Lippe, Noema, streamedup! GmbH, and Vidal. She has received royalties from Elsevier, Medizinisch Wissenschaftliche Verlagsgesellschaft Berlin, and Kohlhammer. She is an associate editor for “Cannabis and Cannabinoid Research” and an Editorial Board Member of “Medical Cannabis and Cannabinoids” und “MDPI‐Reports” and a Scientific board member for “Zeitschrift für Allgemeinmedizin”. A.H. reports lecture fees for Boston Scientific and is a consultant for FxNeuromodulation and Abbott. V.V.V. reports lecture fees for Medtronic and Boston Scientific. J.K.K. is a consultant to Boston Scientific, Medtronic, aleva and Inomed. N.S. has received financial and material research support from the research grant from the Medical University of Warsaw, the Polish Ministry of Health, the Polish Neurological Society, the Foundation for Polish Research, the European Stroke Organization, the American Academy of Neurology, American Brain Foundation and Tourette Association of America. She has received honoraria from Biogen and 90 Consulting. G.R.F. serves as an editorial board member of Cortex, Neurological Research and Practice, NeuroImage: Clinical, Zeitschrift für Neuropsychologie, and Info Neurologie & Psychiatrie; receives royalties from the publication of the books Funktionelle MRT in Psychiatrie und Neurologie, Neurologische Differentialdiagnose, SOP Neurologie, and Therapiehandbuch Neurologie; receives royalties from the publication of the neuropsychological tests KAS and Köpps; received honoraria for speaking engagements from Deutsche Gesellschaft für Neurologie (DGN) and Forum für medizinische Fortbildung FomF GmbH. All other authors report no competing interests.